Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

JDQ443 is a covalent inhibitor of K-RasG12C, a mutant form of K-Ras that accumulates in cancer cells.1 It decreases K-RasG12C-induced phosphorylation of ERK in NCI H358 non-small cell lung cancer (NSCLC) cells (IC50 = 0.020 µM). JDQ443 selectively inhibits the growth of NCI H358 cells, which express K-RasG12C, over NCI H1437 NSCLC cells expressing wild-type K-Ras and the constitutively active mutant MEKQ56P (GI50s = 0.018 and 4.4 µM, respectively). It reduces blood levels of free K-RasG12C at three, six, and 24 hours in a MiaPaCa-2 pancreatic cancer mouse xenograft model when administered at a dose of 30 mg/kg and inhibits tumor growth and decreases tumor volume in the same model at 10 and 30 mg/kg per day.
WARNING This product is not for human or veterinary use.
1. JDQ443, a structurally novel, pyrazole-